Skip to main navigation
Verastem, Inc.

    Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request
  • Our Science
    • Pipeline
    • KRAS G12D Inhibition
    • RAF / MEK / FAK Inhibition
    • Clinical Trials
    • Resources
  • Our Medicines
  • Medical Professionals
    • Overview
    • HCP Resources
      • Request Medical Information
      • Medical Education Grants and Scholarships
      • Investigator Sponsored Trials
      • Expanded Access
  • Patients & Advocacy
  • Investors & Media

    Investor Relations

    • Overview
    • News & Media
      • Press Releases
      • Media Resources
    • Events & Presentations
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • IR Resources
  • Top Bar Links

  • Who We Are
    • Who We Are
    • Leadership
    • Our Culture
  • Careers
  • Contact Us
    • Contact Us
    • General Inquiries
    • Clinical Trial Information
    • Medical Information Request

SEC Filing Details

Document Details

Form
8-K
Filing Date
May 26, 2026
Document Date
May 21, 2026
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Verastem, Inc.
Issuer
Verastem, Inc.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
  • Terms of Use
  • Compliance & Ethics
  • Copyright Statement
  • Privacy Policy
  • Contact
  • Sitemap
Twitter Linkedin
Verastem logo

© 2026 Verastem, Inc. All Rights Reserved.